Skip to main content

US ClosedU.S. Closed

STOK: Stoke Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Stoke Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to developing innovative antisense oligonucleotide (ASO) therapies.

52W Range

60thpctl

Volume

1.01×avg

Market Cap

2.04BUSD

P/E Ratio

-9.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Stoke Therapeutics, Inc.

STOKNASDAQ Global Select·USD·Closed

Stoke Therapeutics, Inc.

STOKNASDAQ·USD·Closed

$31.62

−2.98%

$31.62

−$0.97 (2.98%)

52W Range

60thpctl

Volume

1.01×avg

Mkt Cap

2.04BUSD

P/E

-9.4TTM

Div Yield

–ann